Richmond, Virginia

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Parkinson disease3 trials
• Diabetic eye disease1 trial

Phase

• Phase 33 trials
• Phase 2/31 trial

Status

• Completed3 trials
• Active, not recruiting1 trial

Lead sponsor

• AbbVie3 trials
• EyeBiotech Ltd.1 trial

Running trials

• Active, not recruiting

  A Study to Evaluate the Efficacy and Safety of 2 Doses of Remigromig (EYE103) Compared With Ranibizumab (0.5 mg) in Participants With DME

  NCT06571045· Phase 2/3· EyeBiotech Ltd.· Source

Closed trials

• Completed

  Open-label Trial in Parkinson's Disease (PD)

  NCT04760769· Phase 3· AbbVie· Source

• Completed

  Flexible-Dose, Adjunctive Therapy Trial in Adults With Parkinson's Disease With Motor Fluctuations (TEMPO-3)

  NCT04542499· Phase 3· AbbVie· Source

• Completed

  Flexible-Dose Trial in Early Parkinson's Disease (PD)

  NCT04223193· Phase 3· AbbVie· Source